Opis: The Duration and Safety of Osteoporosis Treatment 2016

Providing a comprehensive review of short-and long-term adverse events of both antiresorptive and anabolic drugs, this practical guide updates the clinician on the pathophysiology of osteoporosis and the principles behind our present and future pharmaceuticals. Leading practitioners in the field examine all current literature and data regarding the duration and safety of these therapies, with recommendations for clinicians on decision-making and best practices for osteoporosis patients. An overview of the pathophysiology and epidemiology of osteoporosis and discussion of both anabolic and antiresorptive drugs is followed by fracture risk assessment and an examination of treatment failures. Next, a number of chapters are dedicated to the diagnosis, presentation and management of atypical femur fractures and osteonecrosis of the jaw (ONJ), each of which are significant patient concerns when using these osteoporosis treatments. The introduction and utilization of drug holidays is also discussed, as well as the long-term outlook for management of osteoporotic patients. Written and edited by experts in the field, The Duration and Safety of Osteoporosis Treatment is a balanced resource for researchers, practitioners and policy-makers alike for clinical decision-making and patient care.Foreword Juliet Compston Preface Chapter 1 Osteoporosis: Pathophysiology & Epidemiology Rebecca J. Moon, Cyrus Cooper, and Nicholas C. Harvey Chapter 2 Antiresorptives R. Graham G. Russell, Maria K. Tsoumpra, Frank H. Ebetino, Michael Pazianas Chapter 3 Anabolics Erik Fink Eriksen Chapter 4 Tools for Assessing Fracture Risk and for Treatment Monitoring William D. Leslie, Lisa M. Lix, and Suzanne N. Morin Chapter 5 Treatment Failure Elisa Torres del Pliego, Daniel Prieto-Alhambra, and Adolfo Diez-Perez Chapter 6 Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures Jeri W. Nieves Chapter 7 Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features Joseph C. Giaconi and C. Travis Watterson Chapter 8 Factors Contributing to Atypical Femoral Fractures Adele L. Boskey and Marjolein C. H. van der Meulen Chapter 9 Clinical Presentation of Atypical Femur Fractures Yelena Bogdan and Thomas A. Einhorn Chapter 10 Effects of Antiresorptive Therapy on Bone Microarchitecture Joy N. T sai and Mary L. Bouxsein Chapter 11 Management of Atypical Femoral Fractures Joseph M. Lane, Libi Z. Galmer, David S. Wellman, Abigail L. Campbell, Jonathan E. Jo Chapter 12 Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features Parish P. Sedghizadeh and Allan C. Jones Chapter 13 Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment Morten Schiodt Chapter 14 Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment Morten Schiodt Chapter 15 Long-Term Efficacy and Safety of Treatments for Osteoporosis Socrates E. Papapoulos Chapter 16 Management of Drug Holidays Christian Roux and Karine Briot Chapter 17 Patients Who Do Not Take Their Osteoporosis Medications: Can We Help Them Become Compliant? Deborah T. Gold Chapter 18 Fractures and Healing on Antiresorptive Therapy Eli Kupperman and Susan V. Bukata Chapter 19 Antiresorptive Therapy and Mortality and Cancer Incidence Peter Vestergaard Chapter 20 Other Safety Concerns Michael R. McClung Chapter 21 The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making Alexandra Papaioannou, Arnav Agarwal, and Sarah Karampatos Chapter 22 Integrated Clinical View on Long-Term Management of Patients with Osteoporosis E. Michael Lewiecki Chapter 23 Conclusions Stuart L. Silverman and Bo Abrahamsen

Szczegóły: The Duration and Safety of Osteoporosis Treatment 2016

Tytuł: The Duration and Safety of Osteoporosis Treatment 2016
Wydawnictwo: Springer Verlag
ISBN: 9783319236384
Rok wydania: 2016
Ilość stron: 338
Oprawa: Miękka
Waga: 0.8 kg

Recenzje: The Duration and Safety of Osteoporosis Treatment 2016